AMETEK, Inc.

NYSE:AME Voorraadrapport

Marktkapitalisatie: US$38.9b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

AMETEK Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

AMETEK heeft een totaal eigen vermogen van $9.3B en een totale schuld van $2.7B, wat de schuld-eigenvermogensverhouding op 28.7% brengt. De totale activa en totale passiva bedragen respectievelijk $14.8B en $5.5B. De EBIT AMETEK is $1.8B waardoor de rentedekking 18.2 is. Het heeft contanten en kortetermijnbeleggingen van $396.6M.

Belangrijke informatie

28.7%

Verhouding schuld/eigen vermogen

US$2.65b

Schuld

Rente dekkingsratio18.2x
ContantUS$396.57m
AandelenUS$9.25b
Totaal verplichtingenUS$5.54b
Totaal activaUS$14.80b

Recente financiële gezondheidsupdates

AMETEK (NYSE:AME) Seems To Use Debt Quite Sensibly

Aug 17
AMETEK (NYSE:AME) Seems To Use Debt Quite Sensibly

AMETEK (NYSE:AME) Seems To Use Debt Rather Sparingly

Apr 14
AMETEK (NYSE:AME) Seems To Use Debt Rather Sparingly

AMETEK (NYSE:AME) Seems To Use Debt Rather Sparingly

Jan 08
AMETEK (NYSE:AME) Seems To Use Debt Rather Sparingly

These 4 Measures Indicate That AMETEK (NYSE:AME) Is Using Debt Safely

Oct 02
These 4 Measures Indicate That AMETEK (NYSE:AME) Is Using Debt Safely

Is AMETEK (NYSE:AME) A Risky Investment?

Jun 27
Is AMETEK (NYSE:AME) A Risky Investment?

AMETEK (NYSE:AME) Could Easily Take On More Debt

Mar 17
AMETEK (NYSE:AME) Could Easily Take On More Debt

Recent updates

Ametek: An Under-The-Radar Pick For Long-Term Gains

Sep 24

Ametek: Headwinds Likely To Persist Into 2025

Sep 09

AMETEK, Inc.'s (NYSE:AME) Price Is Out Of Tune With Earnings

Aug 29
AMETEK, Inc.'s (NYSE:AME) Price Is Out Of Tune With Earnings

AMETEK (NYSE:AME) Seems To Use Debt Quite Sensibly

Aug 17
AMETEK (NYSE:AME) Seems To Use Debt Quite Sensibly

With EPS Growth And More, AMETEK (NYSE:AME) Makes An Interesting Case

Jul 23
With EPS Growth And More, AMETEK (NYSE:AME) Makes An Interesting Case

A Look At The Fair Value Of AMETEK, Inc. (NYSE:AME)

Jul 11
A Look At The Fair Value Of AMETEK, Inc. (NYSE:AME)

Return Trends At AMETEK (NYSE:AME) Aren't Appealing

Jun 26
Return Trends At AMETEK (NYSE:AME) Aren't Appealing

Ametek: Over-Reliance On Acquisitions Deteriorates FCF

Jun 18

Is There Now An Opportunity In AMETEK, Inc. (NYSE:AME)?

Jun 14
Is There Now An Opportunity In AMETEK, Inc. (NYSE:AME)?

Ametek Q1 Update: An Acquisitive And Growth Compounder But Looking Expensive

May 05

AMETEK, Inc.'s (NYSE:AME) Shareholders Might Be Looking For Exit

Apr 26
AMETEK, Inc.'s (NYSE:AME) Shareholders Might Be Looking For Exit

AMETEK (NYSE:AME) Seems To Use Debt Rather Sparingly

Apr 14
AMETEK (NYSE:AME) Seems To Use Debt Rather Sparingly

Here's Why We Think AMETEK (NYSE:AME) Might Deserve Your Attention Today

Mar 21
Here's Why We Think AMETEK (NYSE:AME) Might Deserve Your Attention Today

Slowing Rates Of Return At AMETEK (NYSE:AME) Leave Little Room For Excitement

Mar 08
Slowing Rates Of Return At AMETEK (NYSE:AME) Leave Little Room For Excitement

A Look At The Intrinsic Value Of AMETEK, Inc. (NYSE:AME)

Feb 20
A Look At The Intrinsic Value Of AMETEK, Inc. (NYSE:AME)

AMETEK Q4: Overall Industrial Market Slowdown (Rating Downgrade)

Feb 09

AMETEK, Inc.'s (NYSE:AME) Price Is Out Of Tune With Earnings

Jan 20
AMETEK, Inc.'s (NYSE:AME) Price Is Out Of Tune With Earnings

AMETEK (NYSE:AME) Seems To Use Debt Rather Sparingly

Jan 08
AMETEK (NYSE:AME) Seems To Use Debt Rather Sparingly

Meet AMETEK, One Of The Best Industrial Compounders On The Market

Dec 26

Why AMETEK, Inc. (NYSE:AME) Could Be Worth Watching

Dec 15
Why AMETEK, Inc. (NYSE:AME) Could Be Worth Watching

AMETEK (NYSE:AME) Hasn't Managed To Accelerate Its Returns

Dec 03
AMETEK (NYSE:AME) Hasn't Managed To Accelerate Its Returns

Are Investors Undervaluing AMETEK, Inc. (NYSE:AME) By 36%?

Nov 20
Are Investors Undervaluing AMETEK, Inc. (NYSE:AME) By 36%?

Ametek Q3 Results And New Deals: Impressive, Simply Impressive

Oct 31

Does AMETEK (NYSE:AME) Deserve A Spot On Your Watchlist?

Oct 26
Does AMETEK (NYSE:AME) Deserve A Spot On Your Watchlist?

These 4 Measures Indicate That AMETEK (NYSE:AME) Is Using Debt Safely

Oct 02
These 4 Measures Indicate That AMETEK (NYSE:AME) Is Using Debt Safely

Is There Now An Opportunity In AMETEK, Inc. (NYSE:AME)?

Sep 05
Is There Now An Opportunity In AMETEK, Inc. (NYSE:AME)?

Ametek: A Collection Of Niche Industrial Businesses

Aug 26

Return Trends At AMETEK (NYSE:AME) Aren't Appealing

Aug 21
Return Trends At AMETEK (NYSE:AME) Aren't Appealing

Is AMETEK, Inc. (NYSE:AME) Trading At A 27% Discount?

Aug 07
Is AMETEK, Inc. (NYSE:AME) Trading At A 27% Discount?

With EPS Growth And More, AMETEK (NYSE:AME) Makes An Interesting Case

Jul 11
With EPS Growth And More, AMETEK (NYSE:AME) Makes An Interesting Case

Is AMETEK (NYSE:AME) A Risky Investment?

Jun 27
Is AMETEK (NYSE:AME) A Risky Investment?

Ametek: Earnings Growth And Automation Trends Make It A Buy

Jun 22

Is Now An Opportune Moment To Examine AMETEK, Inc. (NYSE:AME)?

May 31
Is Now An Opportune Moment To Examine AMETEK, Inc. (NYSE:AME)?

AMETEK, Inc. (NYSE:AME) Shares Could Be 29% Below Their Intrinsic Value Estimate

May 08
AMETEK, Inc. (NYSE:AME) Shares Could Be 29% Below Their Intrinsic Value Estimate

Investors Met With Slowing Returns on Capital At AMETEK (NYSE:AME)

Apr 26
Investors Met With Slowing Returns on Capital At AMETEK (NYSE:AME)

Do AMETEK's (NYSE:AME) Earnings Warrant Your Attention?

Apr 01
Do AMETEK's (NYSE:AME) Earnings Warrant Your Attention?

AMETEK (NYSE:AME) Could Easily Take On More Debt

Mar 17
AMETEK (NYSE:AME) Could Easily Take On More Debt

When Should You Buy AMETEK, Inc. (NYSE:AME)?

Feb 14
When Should You Buy AMETEK, Inc. (NYSE:AME)?

Ametek raises dividend by ~14% to $0.25/share

Feb 09

Are Investors Undervaluing AMETEK, Inc. (NYSE:AME) By 21%?

Feb 03
Are Investors Undervaluing AMETEK, Inc. (NYSE:AME) By 21%?

Ametek Q4 2022 Earnings Preview

Feb 01

Ametek: Shares Are Getting Rather Pricey

Jan 24

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $2.8B ) AME } overtreffen de korte termijn passiva ( $2.2B ).

Langlopende schulden: De kortetermijnactiva van AME ( $2.8B ) dekken de langetermijnschulden ( $3.3B ) niet.

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 24.4% ) AME wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van AME is de afgelopen 5 jaar gedaald van 52.9% naar 28.7%.

Schuldendekking: De schuld van AME wordt goed gedekt door de operationele kasstroom ( 68.1% ).

Rentedekking: De rentebetalingen op de schuld van AME worden goed gedekt door EBIT ( 18.2 x dekking).

Balans

Ontdek gezonde bedrijven

7D

1Y

7D

1Y

7D

1Y